Clinical Trials Search Results

  • Resize font
  • Print
  • Email
  • Facebook
  • Twitter
  • Google+
  • Pinterest
Drug:  AKT inhibitor ARQ 092
Find trials that include:  Any drugs shown
Results 1-1 of 1 for your search:
Start Over
Phase 1 Dose Escalation Study of ARQ 092 in Adult Subjects With Advanced Solid Tumors and Recurrent Malignant Lymphoma
Phase: Phase I
Type: Biomarker/Laboratory analysis, Treatment
Age: 18 and over
Trial IDs: ARQ 092-101, NCI-2015-00308, NCT01473095
Start Over